AimoARapezziCVergaroG, et al. Management of complications of cardiac amyloidosis: 10 Questions and answers. Eur J Prev Cardiol. Epub ahead of print 16 April 2020. DOI: 10.1177/2047487320920756.
2.
VergaroGAimoABarisonA, et al. Keys to early diagnosis of cardiac amyloidosis: Red flags from clinical, laboratory and imaging findings. Eur J Prev Cardiol 2020; 27: 1806–1815.
3.
CalòLMartinoATranchitaE, et al.
Electrocardiographic and echocardiographic evaluation of a large cohort of peri-pubertal soccer players during pre-participation screening. Eur J Prev Cardiol2019;
26: 1444–1455.
4.
HeidbuchelHWillemsRJordaensL, et al.
Intensive recreational athletes in the prospective multinational ICD Sports Safety Registry: Results from the European cohort. Eur J Prev Cardiol2019;
26: 764–775.
5.
GeskeJBOngKCSiontisKC, et al.
Women with hypertrophic cardiomyopathy have worse survival. Eur Heart J2017;
38: 3434–3440.
6.
GhiselliLMarchiAFumagalliC, et al. Sex-related differences in exercise performance and outcome of patients with hypertrophic cardiomyopathy. Eur J Prev Cardiol 2020; 27: 1821–1831.
7.
FinocchiaroGPapadakisMDhutiaH, et al.
Obesity and sudden cardiac death in the young: Clinical and pathological insights from a large national registry. Eur J Prev Cardiol2018;
25: 395–401.
8.
FumagalliCMauriziNDaySM, et al.
Association of obesity with adverse long-term outcomes in hypertrophic cardiomyopathy. JAMA Cardiol2020;
5: 65–72.
9.
ParkJBKimDHLeeH, et al. Obesity and metabolic health status are determinants for the clinical expression of hypertrophic cardiomyopathy. Eur J Prev Cardiol 2020; 27: 1849–1857.
10.
GuerraFStronatiGFischiettiC, et al.
Global longitudinal strain measured by speckle tracking identifies subclinical heart involvement in patients with systemic sclerosis. Eur J Prev Cardiol2018;
25: 1598–1606.
11.
BenfariGGrigioniF.Speckle tracking for the diagnosis of subclinical myocardial involvement in systemic sclerosis: A mandatory tool for everyday clinical practice?Eur J Prev Cardiol2018;
25: 1596–1597.
12.
StronatiGManfrediLFerrariniA, et al. Subclinical progression of systemic sclerosis-related cardiomyopathy. Eur J Prev Cardiol 2020; 27: 1876–1886.
13.
SatoYYoshihisaAKimishimaY, et al. Atrial fibrillation is associated with impaired exercise capacity and adverse prognosis in patients with heart failure with mid-range ejection fraction. Eur J Prev Cardiol. Epub ahead of print 16 December 2019. DOI: 10.1177/2047487319894106.
14.
ChangYWooHGParkJ, et al. Improved oral hygiene care is associated with decreased risk of occurrence for atrial fibrillation and heart failure: A nationwide population-based cohort study. Eur J Prev Cardiol 2020; 27: 1835–1845.
15.
Van ItersonEHKimCHUithovenK, et al.
Obesity and hemoglobin content impact peak oxygen uptake in human heart failure. Eur J Prev Cardiol2018;
25: 1937–1946.
16.
LaoutarisID.The ‘aerobic/resistance/inspiratory muscle training hypothesis in heart failure'. Eur J Prev Cardiol2018;
25: 1257–1262.
17.
AngiusLCrisafulliA. Exercise intolerance and fatigue in chronic heart failure: Is there a role for group III/IV afferent feedback? Eur J Prev Cardiol 2020; 27: 1862–1872.
18.
FerriniMJohanssonIAboyansV.Heart failure and its complications in patients with diabetes: Mounting evidence for a growing burden. Eur J Prev Cardiol2019;
26: S106–S113.
19.
RitsingerVNyströmTSalehN, et al. Heart failure is a common complication after acute myocardial infarction in patients with diabetes: A nationwide study in the SWEDEHEART registry. Eur J Prev Cardiol 2020; 27: 1890–1901.
